The sensitivity of ColoSense was 94% for detecting colorectal cancer. The Food and Drug Administration (FDA) has approved ColoSense ™, a noninvasive colorectal cancer screening test for adults 45 ...

The inhalation formulation is expected to deliver treatment directly to the lungs, reducing the potential for systemic toxicity. The Food and Drug Administration (FDA) has granted Fast Track ...

Credit: Masimo. The sensor is contained within the Stork boot, which is secured to the baby’s foot. The system notifies caregivers with visual and audible alarms when oxygen saturation level or PR ...

Credit: Getty Images. What is unusual about this particular case is that it came about due to reliance on an electronic health record system. The EHR that Dr C was using had inexplicably highlighted a ...

A Prescription Drug User Fee Act target date of February 28, 2025 has been assigned to the application. Opdivo, a programmed death-1 (PD-1) immune checkpoint inhibitor, is currently available as a ...

Treatment with LYR-210 did not result in a statistically significant improvement in the composite score of 3 cardinal symptoms of CRS compared with sham. Findings from a phase 3 trial evaluating ...

NeuLumEX and Liquid Polibar Plus are expected to be out of stock in May 2024 and August 2024, respectively. Bracco Diagnostics will no longer be producing NeuLumEX ™ (barium sulfate) Suspension, (0.1% ...

Tarlatamab is an investigational first-in-class, bispecific T-cell engager immunotherapy designed to target delta-like ligand 3 on small cell lung cancer (SCLC) cells and CD3 on T cells.

In a phase 2 trial, 93% of eneboparatide-treated patients were able to discontinue standard of care therapy. The Food and Drug Administration (FDA) has granted Fast Track designation to eneboparatide ...

Ingrezza Sprinkle capsules can be opened and sprinkled over a bowl containing a small amount of soft food. The Food and Drug Administration (FDA) has approved Ingrezza ® Sprinkle (valbenazine ...

Ryplazim is supplied in a 50mL single-dose vial containing 68.8mg of plasminogen as a lyophilized powder for intravenous use after reconstitution. Kedrion Biopharma has resolved its supply issue for ...

A 65-year-old man with type 2 diabetes (T2D) and hyperlipidemia presents for an outpatient visit after recent hospitalization for heart failure. His T2D, managed with diet and metformin, was ...